Quick answer
Kiniksa Pharmaceuticals International, plc (KNSA) reported revenue of $677.6M and net income of $59.0M for the fiscal year ended 2025-12-31, up 60.1% from $423.2M the year before, per its 10-K filed with the SEC on 2026-02-24.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $677.6M | $59.0M | — |
| 2024 (FY ending 2024-12-31) | $423.2M | -$43.2M | — |
| 2023 (FY ending 2023-12-31) | $270.3M | $14.1M | — |
| 2022 (FY ending 2022-12-31) | $220.2M | $183.4M | — |
| 2021 (FY ending 2021-12-31) | $38.5M | -$157.9M | — |
| 2020 (FY ending 2020-12-31) | — | -$161.4M | — |
| 2019 (FY ending 2019-12-31) | — | -$161.9M | — |
| 2018 (FY ending 2018-12-31) | — | -$103.2M | — |
| 2017 (FY ending 2017-12-31) | — | -$64.9M | — |
Frequently asked questions
What is Kiniksa Pharmaceuticals International, plc's annual revenue?
Kiniksa Pharmaceuticals International, plc (KNSA) reported revenue of $677.6M and net income of $59.0M for the fiscal year ended 2025-12-31, up 60.1% from $423.2M the year before, per its 10-K filed with the SEC on 2026-02-24.
What is KNSA's profit margin?
Kiniksa Pharmaceuticals International, plc's net margin was 8.7% in the fiscal year ended 2025-12-31.
Related
- KMB revenue, net income and debt history (Kimberly-Clark Corporation)
- KMI revenue, net income and debt history (Kinder Morgan, Inc.)
- KN revenue, net income and debt history (Knowles Corporation)
- KNSL revenue, net income and debt history (Kinsale Capital Group, Inc.)
- KNTK revenue, net income and debt history (Kinetik Holdings Inc.)
- KNX revenue, net income and debt history (Knight-Swift Transportation Holdings Inc.)
- KO revenue, net income and debt history (Coca Cola Co)
- KOSS revenue, net income and debt history (Koss Corporation)
Last updated Oct 23, 2026, 7:21 AM ET. Data only, not financial or tax advice.
Related answers
- KNSA stock split history (Kiniksa Pharmaceuticals International, plc)
- KNSA earnings report dates and EPS history (Kiniksa Pharmaceuticals International, plc)
Tools & live data
What's Moving Right Now
#1 Nasdaq-100 moverAMD $507.93 -8.10%Nasdaq, as of Oct 22, 2026 4:15 PM ET
Trading halts18 halts in Nasdaq's current feedNasdaq Trader feed, checked Oct 23, 7:30 AM ET
Earnings & SEC 8-Ks14 companies report Oct 23 · 8-Ks todayNasdaq earnings calendar, SEC EDGAR